These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives. Hertz R Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601 [No Abstract] [Full Text] [Related]
9. [Malignant disorders in rheumatoid arthritis; the influence of treatment with cyclophosphamide]. Baltus JA; Boersma JW; Vandenbroucke JP Ned Tijdschr Geneeskd; 1984 Feb; 128(5):205-9. PubMed ID: 6700762 [No Abstract] [Full Text] [Related]
10. Steroid hormones and medications that alter cancer risks. Thomas DB Cancer; 1988 Oct; 62(8 Suppl):1755-67. PubMed ID: 3048637 [TBL] [Abstract][Full Text] [Related]
11. Drugs affecting therapy with anticoagulants. Eipe J Med Clin North Am; 1972 Jan; 56(1):255-62. PubMed ID: 4550190 [No Abstract] [Full Text] [Related]
12. [Long-term use of estrogens: benefit or risk]. Pietrzak B; Wlaźlak E; Zwierzyńska E Postepy Hig Med Dosw (Online); 2015 Mar; 69():285-93. PubMed ID: 25748619 [TBL] [Abstract][Full Text] [Related]
13. Principles of oral contraception. 2. Side effects of oral contraceptives. Carey HM Med J Aust; 1971 Dec; 2(24):1242-50. PubMed ID: 4945334 [No Abstract] [Full Text] [Related]
14. [Drug-induced liver damage; new aspects on its mechanism]. Salaspuro M Duodecim; 1980; 96(5):394-402. PubMed ID: 6893817 [No Abstract] [Full Text] [Related]
17. Serious adverse effects of oral contraceptives and estrogens. Med Lett Drugs Ther; 1976 Feb; 18(5):21-2. PubMed ID: 1256357 [No Abstract] [Full Text] [Related]
18. Cancer risks of medical treatment. Part II: potentially carcinogenic medications in current use. Schottenfeld D Clin Bull; 1981; 11(2):75-82. PubMed ID: 7034995 [No Abstract] [Full Text] [Related]
19. [Carcinogenic effects of antineoplastic and immunosuppressive agents]. Brock N; Schneider H Arzneimittelforschung; 1971 Sep; 21(9):1406-10. PubMed ID: 5171799 [No Abstract] [Full Text] [Related]
20. The use of vital and morbidity statistics for the detection of adverse drug reactions and for monitoring of drug safety. Stolley PD J Clin Pharmacol; 1982; 22(11-12):499-504. PubMed ID: 7161406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]